We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SBFM Sunshine Biopharma Inc

0.023 (9.35%)
Last Updated: 14:31:56
Delayed by 15 minutes


Draw Mode:

Volume 100,056
Bid Price 0.2622
Ask Price 0.2698
News -
Day High 0.28


52 Week Range


Day Low 0.255
Company Name Stock Ticker Symbol Market Type
Sunshine Biopharma Inc SBFM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.023 9.35% 0.269 14:31:56
Open Price Low Price High Price Close Price Prev Close
0.2773 0.255 0.28 0.246
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
324 100,056 $ 0.2656876 $ 26,584 - 0.2053 - 1.40
Last Trade Time Type Quantity Stock Price Currency
14:24:55 100 $ 0.269 USD

Sunshine Biopharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.95M 25.75M - 4.35M -26.74M -1.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sunshine Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SBFM Message Board. Create One! See More Posts on SBFM Message Board See More Message Board Posts

Historical SBFM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.27980.31860.20530.2565636946,763-0.0108-3.86%
1 Month0.29920.320.20530.2608164284,872-0.0302-10.09%
3 Months0.4090.4320.20530.2915309147,106-0.14-34.23%
6 Months0.600.67010.20530.4356891181,133-0.331-55.17%
1 Year0.811.400.20530.7903435477,423-0.541-66.79%
3 Years2.759.870.20534.392,132,960-2.48-90.22%
5 Years2.759.870.20534.392,132,960-2.48-90.22%

Sunshine Biopharma Description

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |